Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Heisman
    Senior Member
    • Dec 2010
    • 534

    #1

    Calculating Ti/Tv ratio

    Hey all,

    Quick question. When, for example, it's stated that for human exomes a Ti/Tv ratio of around 3.0 is expected, does that refer to the number of transitions divided by the number of transversions, or the number of transitions multiplied by 2 divided by the number of transversions (ie, absolute counts or rates)? I've been googling around and I think it's rates but I want to be absolutely sure that the commonly reported expected ratios refer to rates as well. Thanks for any help.
  • SES
    Senior Member
    • Mar 2010
    • 275

    #2
    It sounds like you are confusing the Ti/Tv ratio with the ratio of the Ti/Tv rates. The first calculation you mention would be like something you would do to get the ratio of the rates. The Ti/Tv ratio is simply the ratio of the number of transitions to the number of transversions for a pair of sequences. Be sure to pay attention to the model of evolution used in the studies you are referring to, otherwise you may not get the same results.

    Comment

    • Heisman
      Senior Member
      • Dec 2010
      • 534

      #3
      Originally posted by SES View Post
      It sounds like you are confusing the Ti/Tv ratio with the ratio of the Ti/Tv rates. The first calculation you mention would be like something you would do to get the ratio of the rates. The Ti/Tv ratio is simply the ratio of the number of transitions to the number of transversions for a pair of sequences. Be sure to pay attention to the model of evolution used in the studies you are referring to, otherwise you may not get the same results.
      Ok, so for example, if I have 100 SNPs, 75 of them are transitions, and 25 are transversions, then the Ti/Tv ratio would be 75:25 = 3.0? Based on the last paragraph here http://www.broadinstitute.org/gsa/wi...php/QC_Methods , it looks like that calculation (75/25) would suffice and give me an expected value for an exome.

      But then, reading the second reply here http://www.biostars.org/post/show/47...ral-rule/#4758 indicates I should be multiplying by a factor of 2, if I understand correctly. Hence, it would be 75*2/25 = 6.0

      I'm still not sure if I should throw in that factor of 2 when comparing to established whole genome or whole exome values.

      Comment

      • SES
        Senior Member
        • Mar 2010
        • 275

        #4
        I believe the discussion you are referring to in the latter link is about the observed difference in Ti/Tv rates for the whole genome vs. those rates when only looking at exome data. The first link also has a discussion of this point in that final paragraph. I don't think you should be multiplying by any factor. There is a worked example of this calculation on the snpEff homepage that may clarify this point.

        Comment

        • Heisman
          Senior Member
          • Dec 2010
          • 534

          #5
          Originally posted by SES View Post
          I believe the discussion you are referring to in the latter link is about the observed difference in Ti/Tv rates for the whole genome vs. those rates when only looking at exome data. The first link also has a discussion of this point in that final paragraph. I don't think you should be multiplying by any factor. There is a worked example of this calculation on the snpEff homepage that may clarify this point.
          Ah, cool. No multiplication factor then. Thanks!

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 10:52 AM
          0 responses
          9 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-13-2026, 09:56 AM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-09-2026, 11:14 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Working...